XML 56 R35.htm IDEA: XBRL DOCUMENT v3.25.4

Share-Based Compensation (Tables)

12 Months Ended

Oct. 31, 2025

Share-Based Payment Arrangement [Abstract]

Schedule of Shares Reserved for Future Issuance Under the Plan

As of October 31, 2025, and 2024, the Company has reserved the following Common Shares for the exercise of Common Share warrants, share options, and remaining shares reserved for future issuance under the 2023 Plan and options granted outside of the 2023 Plan as part of the inducement grants:

		October 31,				October 31,
		2025				2024
Warrants to purchase common shares			8,511,968				8,511,968
Incentive options to purchase common shares awarded pursuant to the 2023 Plan			5,717,948				4,391,512
Inducement grant stock options awarded outside of the 2023 Plan			3,315,350				1,643,000
Remaining shares reserved for future issuance under    the 2023 Plan			2,933,304				2,752,889
Remaining shares reserved for future issuance under ESPP			2,000,000				—
Total			22,478,570				17,299,369

Schedule of Assumptions Used to Determine Grant-Date Fair Value of Stock Options

The assumptions that the Company used to determine the grant-date fair value of stock options during the years ended October 31, 2025 and 2024, were as follows:

	Year ended October 31,
	2025					2024
Expected term (in years)		5.5-6.08				5.51 - 6.08
Expected volatility		78.78-83.53%				78.24 - 82.33%
Risk-free interest rate		3.84-4.49%				1.78 - 4.66%
Expected dividend yield			—				—
Fair value of common shares and exercise price of options (USD)	$	3.31-7.39			$	4.73 - 12.60

Summary of Stock Option Activity

The following table summarizes the Company’s stock option activity:

		Number of Shares				Weighted- Average Exercise Price (USD)				Weighted- Average Remaining Contractual Term (in years)				Aggregate Intrinsic Value
Outstanding as of October 31, 2024			6,034,512			$	6.88				7.4			$	17,809
Granted			4,926,875				6.41
Exercised			(1,041,982	)			2.13
Forfeited or expired			(886,107	)			9.86
Outstanding as of October 31, 2025			9,033,298			$	6.93				8.5			$	10,979
Options vested and exercisable as of October 31, 2025			2,935,183			$	6.07				7.0			$	6,497
Options unvested as of October 31, 2025			6,098,115			$	7.35			$	9.2			$	4,482

Summary of Share-based Compensation Expense

Share-based compensation expense included in the Company’s consolidated statements of operations and comprehensive loss was as follows:

		Year Ended October 31,
		2025				2024
Research and development		$	3,282			$	1,794
General and administrative			6,364				3,530
Total share-based compensation expense		$	9,646			$	5,324

X

- Definition

Schedule of shares reserved for future issuance under the plan.

+ References

No definition available.

+ Details

Name:	engn_ScheduleOfSharesReservedForFutureIssuanceUnderThePlanTableTextBlock
Namespace Prefix:	engn_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (f)(2)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration